Genes for Induction of T Cell Responses

诱导 T 细胞反应的基因

基本信息

  • 批准号:
    7756631
  • 负责人:
  • 金额:
    $ 45.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-02-01 至 2010-01-31
  • 项目状态:
    已结题

项目摘要

The extraordinary genetic diversity among globally circulating HIV-1 strains poses a formidable challenge for HIV-1 vaccine design. Therefore, AIDS vaccines that can induce broadly reactive and potent T cell immune responses are urgently needed. In our recent studies, we have generated two synthetic group M consensus env genes (CON6 and CON-S) of all HIV-1 subtypes. The genetic distance between the group M consensus env sequences and any subtype env sequences is only half of those among subtype env sequences to each other (15% vs. 30%). Our preliminary results have shown that both CON6 and CON-S were biologically functional, preserved key antibody binding epitopes and, most importantly, induced T cell responses in three strains of mice that were more cross-reactive than single subtype env immunogens, and were similar in breadth to a subtype A, B and C env polyvalent immunogen. Project 3 will test T cell immune responses induced by a spectrum of centralized HIV-1 genes in mice using a DMA prime-recombinant vaccinia virus boost screening strategy, and comprehensively evaluate the centralized gene approach for development of HIV-1 immunogens that induce potent cross-reactive anti-HIV-1 T cell responses. We will: 1) identify optimal consensus env immunogens that induce broad cross-reactive T cell responses, 2) determine which centralized immunogen designs can induce the broadest T cell immune responses in mice, 3) determine if the group M consensus gag-pol-nef fusion gene immunogens can induce broader T cell immune responses than contemporary subtype (A, B and C) gag-pol-nef fusion gene immunogens, and 4) study the subtype consensus env immunogens from acute infection viruses and other newer generations of centralized genes from Project 1 to identify optimal immunogens for inducing broadly reactive T cell responses. The immunogens that induce optimal T cell responses will be evaluated in non-human primates in Project 4.
在全球传播的HIV-1毒株中,非同寻常的遗传多样性构成了一个可怕的威胁

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FENG GAO其他文献

FENG GAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FENG GAO', 18)}}的其他基金

Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
中和抗体在 HIV-1 感染和接种疫苗的母亲中在 MTCT 中的作用
  • 批准号:
    9294963
  • 财政年份:
    2016
  • 资助金额:
    $ 45.15万
  • 项目类别:
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
中和抗体在 HIV-1 感染和接种疫苗的母亲中在 MTCT 中的作用
  • 批准号:
    9064432
  • 财政年份:
    2016
  • 资助金额:
    $ 45.15万
  • 项目类别:
Critical domains for HIV-1 entry through atypical coreceptor usage
通过非典型辅助受体使用进入 HIV-1 的关键领域
  • 批准号:
    8712360
  • 财政年份:
    2013
  • 资助金额:
    $ 45.15万
  • 项目类别:
Critical domains for HIV-1 entry through atypical coreceptor usage
通过非典型辅助受体使用进入 HIV-1 的关键领域
  • 批准号:
    8540772
  • 财政年份:
    2013
  • 资助金额:
    $ 45.15万
  • 项目类别:
Genes for Induction of T Cell Responses
诱导 T 细胞反应的基因
  • 批准号:
    7006821
  • 财政年份:
    2005
  • 资助金额:
    $ 45.15万
  • 项目类别:
Immunogenicity of an HIV virus-like particle vaccine
HIV病毒样颗粒疫苗的免疫原性
  • 批准号:
    6590286
  • 财政年份:
    2003
  • 资助金额:
    $ 45.15万
  • 项目类别:
Role of Virus Recombination in Multiple Drug Resisitance
病毒重组在多重耐药性中的作用
  • 批准号:
    6693386
  • 财政年份:
    2003
  • 资助金额:
    $ 45.15万
  • 项目类别:
A Universal Env Immunogen for all HIV-1 Subtypes
适用于所有 HIV-1 亚型的通用包膜免疫原
  • 批准号:
    6797893
  • 财政年份:
    2003
  • 资助金额:
    $ 45.15万
  • 项目类别:
Immunogenicity of an HIV virus-like particle vaccine
HIV病毒样颗粒疫苗的免疫原性
  • 批准号:
    6701755
  • 财政年份:
    2003
  • 资助金额:
    $ 45.15万
  • 项目类别:
Role of Virus Recombination in Multiple Drug Resisitance
病毒重组在多重耐药性中的作用
  • 批准号:
    6590226
  • 财政年份:
    2003
  • 资助金额:
    $ 45.15万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 45.15万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了